Contemporary outcomes of bladder carcinoma in situ treated with an adequate bacille Calmette-Guerin immunotherapy.
Subiela JD, Rodríguez Faba Ó, Aumatell J, Calderón J, Mercadé A, Balañà J, Esquinas C, Algaba F, Breda A, Palou J.
BJU Int. 2022 Apr;129(4):542-550. doi: 10.1111/bju.15567. Epub 2021 Aug 23.
Detection and resection of carcinoma in situ of the bladder: Implications for clinical trial design.
Roumiguié M, Wong A, Belanger E, Wang G, Black PC.
Urol Oncol. 2023 May;41(5):254.e9-254.e15. doi: 10.1016/j.urolonc.2022.10.033. Epub 2022 Dec 22.
Carcinoma in situ of the bladder.
Hudson MA, Herr HW.
J Urol. 1995 Mar;153(3 Pt 1):564-72. doi: 10.1097/00005392-199503000-00002.
Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis.
Nese N, Gupta R, Bui MH, Amin MB.
J Natl Compr Canc Netw. 2009 Jan;7(1):48-57. doi: 10.6004/jnccn.2009.0004.
Mixed Adenocarcinomatous and Neuroendocrine Tumor of the Urinary Bladder With Concomitant Carcinoma In Situ: A Case Report With a Comprehensive Immunohistochemical Analysis and Review of the Literature.
Tränkenschuh W, Biesdorf AS, Papadimas N, Samara S, Hefty R, Stahl PR.
Int J Surg Pathol. 2019 Sep;27(6):684-692. doi: 10.1177/1066896919839781. Epub 2019 Apr 8.
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.
Paner GP, Kamat A, Netto GJ, Samaratunga H, Varma M, Bubendorf L, van der Kwast TH, Cheng L; Members of the ISUP Bladder Tumor Consensus Panel.
Am J Surg Pathol. 2024 Jan 1;48(1):e11-e23. doi: 10.1097/PAS.0000000000002077. Epub 2023 Jun 29.
Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: the state of the art.
Williamson SR, Montironi R, Lopez-Beltran A, MacLennan GT, Davidson DD, Cheng L.
Crit Rev Oncol Hematol. 2010 Nov;76(2):112-26. doi: 10.1016/j.critrevonc.2010.01.005. Epub 2010 Jan 25.
Pathology of carcinoma in situ of the urinary bladder and related lesions.
Farrow GM.
J Cell Biochem Suppl. 1992;16I:39-43. doi: 10.1002/jcb.240501308.
The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder.
Kim JC, Steinberg GD.
J Urol. 2001 Mar;165(3):745-56.
A paclitaxel-hyaluronan conjugate (ONCOFID-P-B) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the tumor microenvironment.
Tosi A, Parisatto B, Gaffo E, Bortoluzzi S, Rosato A.
J Exp Clin Cancer Res. 2024 Apr 10;43(1):109. doi: 10.1186/s13046-024-03028-5.
